[HTML][HTML] FDA-ARGOS is a database with public quality-controlled reference genomes for diagnostic use and regulatory science

H Sichtig, T Minogue, Y Yan, C Stefan, A Hall… - Nature …, 2019 - nature.com
FDA proactively invests in tools to support innovation of emerging technologies, such as
infectious disease next generation sequencing (ID-NGS). Here, we introduce FDA-ARGOS …

FDA-ARGOS is a database with public quality-controlled reference genomes for diagnostic use and regulatory science.

H Sichtig, T Minogue, Y Yan, C Stefan… - Nature …, 2019 - search.ebscohost.com
FDA proactively invests in tools to support innovation of emerging technologies, such as
infectious disease next generation sequencing (ID-NGS). Here, we introduce FDA-ARGOS …

FDA-ARGOS is a database with public quality-controlled reference genomes for diagnostic use and regulatory science

H Sichtig, T Minogue, Y Yan, C Stefan… - Nature …, 2019 - pubmed.ncbi.nlm.nih.gov
FDA proactively invests in tools to support innovation of emerging technologies, such as
infectious disease next generation sequencing (ID-NGS). Here, we introduce FDA-ARGOS …

FDA-ARGOS is a database with public quality-controlled reference genomes for diagnostic use and regulatory science

H Sichtig, T Minogue, Y Yan, C Stefan, A Hall… - Nature …, 2019 - osti.gov
FDA proactively invests in tools to support innovation of emerging technologies, such as
infectious disease next generation sequencing (ID-NGS). Here, we introduce FDA-ARGOS …

FDA-ARGOS is a database with public quality-controlled reference genomes for diagnostic use and regulatory science

H Sichtig, T Minogue, Y Yan, C Stefan… - Nature …, 2019 - econpapers.repec.org
FDA proactively invests in tools to support innovation of emerging technologies, such as
infectious disease next generation sequencing (ID-NGS). Here, we introduce FDA-ARGOS …

FDA-ARGOS is a database with public quality-controlled reference genomes for diagnostic use and regulatory science

H Sichtig, T Minogue, Y Yan, C Stefan, A Hall… - Nature …, 2019 - ideas.repec.org
FDA proactively invests in tools to support innovation of emerging technologies, such as
infectious disease next generation sequencing (ID-NGS). Here, we introduce FDA-ARGOS …

FDA-ARGOS is a database with public quality-controlled reference genomes for diagnostic use and regulatory science

H Sichtig, T Minogue, Y Yan, C Stefan… - Nature …, 2019 - ui.adsabs.harvard.edu
FDA proactively invests in tools to support innovation of emerging technologies, such as
infectious disease next generation sequencing (ID-NGS). Here, we introduce FDA-ARGOS …

FDA-ARGOS is a database with public quality-controlled reference genomes for diagnostic use and regulatory science.

H Sichtig, T Minogue, Y Yan, C Stefan, A Hall… - Nature …, 2019 - europepmc.org
FDA proactively invests in tools to support innovation of emerging technologies, such as
infectious disease next generation sequencing (ID-NGS). Here, we introduce FDA-ARGOS …

[HTML][HTML] FDA-ARGOS is a database with public quality-controlled reference genomes for diagnostic use and regulatory science

H Sichtig, T Minogue, Y Yan, C Stefan, A Hall… - Nature …, 2019 - ncbi.nlm.nih.gov
FDA proactively invests in tools to support innovation of emerging technologies, such as
infectious disease next generation sequencing (ID-NGS). Here, we introduce FDA-ARGOS …

FDA-ARGOS is a database with public quality-controlled reference genomes for diagnostic use and regulatory science

H Sichtig, T Minogue, Y Yan, C Stefan, A Hall… - Nature …, 2019 - hero.epa.gov
FDA proactively invests in tools to support innovation of emerging technologies, such as
infectious disease next generation sequencing (ID-NGS). Here, we introduce FDA-ARGOS …